HOME >> MEDICINE >> NEWS
Institute of Medicine advisory: Drug safety news conference September 26

Recent recalls of prescription drugs and other events have led to concerns about how well the drug safety system monitors and addresses the safety of prescription medications after they reach the market. THE FUTURE OF DRUG SAFETY: PROMOTING AND PROTECTING THE HEALTH OF THE PUBLIC, a new report from the Institute of Medicine, assesses the system's strengths and shortcomings and offers a plan for improving the evaluation of medications on an ongoing basis. The report will be released at a one-hour news conference on Tuesday, Sept. 26.

DETAILS:
11 a.m. in in the Lecture Room of the National Academies building, 2100 C St., N.W., Washington, D.C. Those who cannot attend may listen to a live audio webcast and submit questions using an e-mail form at http://national-academies.org.

PARTICIPATING FROM THE COMMITTEE THAT WROTE THE REPORT:
-- Sheila Burke, deputy secretary and chief operating officer, Smithsonian Institution, Washington, D.C.
-- Alta Charo, professor of law, School of Law; and professor of bioethics, School of Medicine, University of Wisconsin, Madison
-- Bruce Psaty, professor of medicine, epidemiology, and health services, Cardiovascular Health Research Unit, University of Washington, Seattle

REPORTERS: OBTAIN AN ADVANCE COPY OR REGISTER TO ATTEND by contacting the National Academies' Office of News and Public Information at tel. 202-334-2138 or e-mail news@nas.edu. Advance copies of the report will be available to reporters only beginning at 8:30 a.m. EDT on Tuesday, Sept. 26. THE REPORT IS EMBARGOED AND NOT FOR PUBLIC RELEASE BEFORE 11 A.M. EDT ON SEPT. 26.


'"/>

Contact: Christine Stencel
news@nas.edu
202-334-2138
The National Academies
20-Sep-2006


Page: 1

Related medicine news :

1. Worcester Polytechnic Institute to host national forum on locating first responders inside buildings
2. Wesley Research Institute study targets pharmacists to help diabetes sufferers
3. CIRM awards $3.79 million to Burnham Institute
4. Institute of Medicine Advisory: Public health physicians
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Dr. Eli Peli of Schepens Eye Research Institute elected SPIE fellow
9. AGA Institute takes leadership role in exploring obesity and its complications
10. Kavli Institutes Journalist Workshop, June 13, at Cornell
11. National Academy of Sciences Institute of Medicine report calls for more dairy foods at school

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology:
Cached News: